Amarin Corp Plc (AMRN)

[JRoon71]

BBI, normally I would agree (with a typical "new drug"). However, I think in this case, the generics might have seen the writing on the wall that Omega-3's are becoming wildly popular right now, and they wanted to hitch their wagon to that horse. All Omega-3's are enjoying a nice run right now with virtually zero out-of-pocket marketing...Lovaza, Vascepa, generics, and OTC fish oil.

In hindsight, you are right. If Amarin had never lost the patents, and had free run of marketing the past 3 years, I would suspect their run rate would be probably double what it is now. Maybe more. Just over two years ago we were at 100,000 scripts a week and growing (we doubled scripts in about 18 months), and we had just expanded the salesforce and were barely marketing.

What we also can't account for is the fact that all of the additional cashflow would have moved up all plans for marketing and rollouts of new formulations.

Losing the patent protection had such a profound and magnified impact on Amarin. More than I think many people even realize. Everything since then has simply been defensive/scramble mode.